ABSTRACT
Maternal and infant microbiome dysbiosis is associated with poor health outcomes—gut, vaginal, and placental microbiome disruptions in the gut, vaginal, and potentially placental microbiomes—though the existence of a distinct placental microbiome remains controversial—have been linked to pregnancy difficulties and neonatal infections. Dysbiosis leads to inflammation, oxidative stress, and disruptions in the gut-brain axis, which in turn affect immunological control, metabolic balance, and neurodevelopment. Maternal age, antibiotic exposure, and cesarean delivery increase microbial imbalances, raising the risk of preterm birth, gestational diabetes, and neurodevelopmental disorders. New research highlights the importance of systems-level microbial interactions in the gut-vagina axis and maternal-fetal health. Probiotics, prebiotics, and microbiota transplants may treat microbiome disorders. To reduce dysbiosis risks, research should focus on microbiome-based biomarkers, predictive AI models, and global health policy. Understanding microbial interactions at the system level is essential for maternal and child health.
KEYWORDS: microbial dysbiosis, maternal microbiome, gut-vagina axis, pregnancy complications, neonatal infections, immune dysregulation, gut-brain axis, microbiota interventions, precision medicine, oxidative stress
DYSBIOSIS AS A GLOBAL HEALTH CHALLENGE
A growing number of researchers identify microbial dysbiosis, which describes an imbalance in the human microbiome, as crucial to maternal and child health outcomes (1). Recent evidence highlights microbial dysbiosis as a critical factor influencing maternal and child health outcomes. The gut microbiota, along with other elements of the human microbiome, plays a fundamental role in shaping immune development, metabolic control, and brain growth (2). The adverse health effects stem from modifications made to the microbial composition that result from contemporary lifestyles, antibiotic misuse, environmental elements, and modern influences (3).
The United Nations Sustainable Development Goals prioritize efforts to reduce deaths during motherhood and infancy and address communicable and non-communicable diseases due to their importance in Sustainable Development Goals through 3.4 (4). New research shows that dysbiosis creates pregnancy complications as well as affects neonatal infections and leads to lasting health problems in children (5). This growing evidence underscores the need to integrate microbiome health into global maternal and child health policies (6).
RELEVANCE TO MATERNAL AND PEDIATRIC DISEASES
An irregular microbial makeup leads to significant healthcare problems that influence both maternal outcomes and child health during growth and increase disease risk in the future (7). The entire microbiome of a pregnant woman, which includes her gut bacteria and vaginal and placental microorganisms, directly influences both fetal immune system development and metabolic processes (8). The complex microbial equilibrium depends on both beneficial microbes and controls pathogenic bacteria growth because any disturbance could lead to preterm birth, plus gestational diabetes and preeclampsia (9).
Immune tolerance development and protection against infections require the necessary microbial colonization processes, which begin at birth and continue throughout early infancy (10). Infants born through cesarean section receive a different microbiome from vaginally delivered infants, resulting in elevated vulnerability toward allergic conditions, asthma, and metabolic diseases (11).
The different bacterial makeup in infants born through c-section results in elevated vulnerability toward allergic conditions, asthma, and metabolic diseases (12). The diversity of gut microbes during infancy is disrupted by various infant care factors, including formula feeding, antibiotics, and environmental contaminants, which can lead to childhood obesity, inflammatory bowel disease, and neurodevelopmental disorders (13, 14). For instance, early-life gut microbiota alterations correlate with childhood obesity through changes in nutrient absorption and inflammation (13). Similarly, dysbiosis is linked to inflammatory bowel disease and neurodevelopmental disorders like autism spectrum disorder (ASD), though causal relationships remain under investigation in humans (15, 16).
LINKAGE OF DYSBIOSIS TO DISEASES
This review aims to explore the disease mechanisms associated with microbial dysbiosis in maternal and child health. Research indicates that dysbiosis can
Induce immune dysregulation—dysbiosis is linked to an imbalance between pro-inflammatory and anti-inflammatory microbial metabolites, which may contribute to persistent low-grade inflammation and increased susceptibility to autoimmune diseases (17).
Disruption of metabolic balance—changes in the gut microbiome of both mother and infant affect nutrient metabolism, insulin sensitivity, and energy regulation, playing a role in obesity and metabolic disorders (13, 18). For example, early-life dysbiosis correlates with childhood obesity through altered nutrient absorption (19).
Influence neurodevelopment through the gut-brain connection—dysbiosis is associated with altered synthesis of neuroactive compounds and short-chain fatty acids, which may influence cognitive function and increase the risk of neurodevelopmental disorders, such as ASD and attention-deficit/hyperactivity disorder (15, 20). For instance, studies have identified distinct gut microbiota profiles in ASD patients, but causal mechanisms in humans remain unclear (21). Similarly, dysbiosis is linked to asthma risk, particularly in early life, though causal relationships require further investigation (22).
This review aims to clarify these mechanisms and emphasize potential interventions targeting the microbiome, such as probiotics, prebiotics, fecal microbiota transplantation, and precision microbiome therapeutics, which may mitigate the adverse effects of dysbiosis on maternal and child health. The pathways linking dysbiosis to adverse health outcomes are summarized in Fig. 1.
Fig 1.
Simplified pathway illustrating the associations between microbial dysbiosis and disease mechanisms in maternal and child health.
DYSBIOSIS IN MATERNAL AND CHILDBIRTH
Advanced maternal age (AMA) is defined as a pregnancy in a woman older than 35 years of age. AMA increases the risk for both maternal and neonatal complications, including miscarriage and stillbirth (23). Research on the specific contribution of the maternal microbiome to pregnancy outcomes and offspring behavior, conducted by recolonizing young female mice with an aged female microbiome before pregnancy, suggests that pre-pregnancy colonization of young dams with the aged microbiome significantly increases fetal loss. This indicates that the composition of the maternal gut microbiome can have a detrimental impact on pregnancy outcomes. Offspring from dams with an aged microbiome exhibited significant changes in neurotransmitters and metabolites in both the blood and the brain (24). The study indicated that age-related changes in the maternal gut microbiome can lead to chronic alterations in the behavior and physiology of offspring (25). Bacterial vaginosis (BV) during pregnancy is a significant risk factor for preterm birth and other preterm pregnancy complications. BV exposure during gestation is linked to worse neonatal outcomes, even in infants delivered at full term (26). Preeclampsia is a predominant cause of maternal and neonatal morbidity and mortality globally (27). Preeclampsia, a complication of pregnancy characterized by hypertension and organ dysfunction, is associated with gut microbiota dysbiosis, characterized by reduced bacterial diversity and enrichment of opportunistic pathogens, which may contribute to inflammation, endothelial dysfunction, and placental damage (28, 29). For example, studies have shown that patients with pre-eclampsia exhibit distinct gut microbiota profiles, but whether dysbiosis directly causes these complications requires further human mechanistic studies (29).
Microbial shifts and changes in microbial diversity play an important role in maternal health. A study involved a cohort of 2,313 pregnant women, focusing on the vaginal microbiota and its relationship with pregnancy outcomes. A study reveals that Gardnerella vaginalis, commonly linked to bacterial vaginosis, was detected in 77% of samples and accounted for approximately 10% of the total reads. The study found that the overall diversity of the vaginal microbiota was higher in samples from women at risk of preterm delivery (30). Table 1 summarizes the key factors contributing to microbial dysbiosis and their associated health outcomes in maternal and child health.
TABLE 1.
Key factors contributing to microbial dysbiosis in maternal and child health
| Factor | Mechanism of dysbiosis | Associated health outcomes | References |
|---|---|---|---|
| Advanced maternal age | Altered gut microbiome composition, reduced microbial diversity | Increased fetal loss, neurobehavioral changes in offspring | (31) |
| Antibiotic exposure | Disruption of beneficial microbes, overgrowth of pathogens | Preterm birth, neonatal infections, metabolic disorders | (32) |
| Cesarean delivery | Lack of vaginal microbial transfer, altered infant microbiome | Higher risk of allergies, asthma, obesity | (33) |
| Bacterial vaginosis | Overgrowth of pathogens (e.g., Gardnerella vaginalis) | Preterm birth, neonatal morbidity | (34) |
| Environmental contaminants | Shift in microbial balance, reduced beneficial species | Childhood obesity, inflammatory bowel disease | (35) |
Another study reveals that the multi-omics approach and analysis can discover changes in gut microbiota and metabolites during pregnancy that impact immune function. The researchers performed correlation analyses and concluded that there was a marked reduction in pro-inflammatory cytokine levels in pregnant women. The study revealed that bacteria within the same microbial modules had consistent effects on cytokine levels. This suggests that these bacteria may function collectively, influencing immune responses rather than individually (36).
DISEASE MECHANISMS AND CONSEQUENCES
Inflammation, Oxidative Stress, and Immune Dysregulation
Microbial dysbiosis destroys the balanced interactions between microbiota and hosts, which sets off inflammation and oxidative stress processes that bring about maternal and child health difficulties (37). During pregnancy, immune regulation strongly depends on the maternal gut and vaginal microbiomes (38). The inflammation caused by dysbiosis leads to overproduction of pro-inflammatory cytokines like IL-6, TNF-α (alpha), and IL-1 that result in preterm birth and preeclampsia as adverse pregnancy effects (39).
The process of oxidative stress develops from excessive production of reactive oxygen species to worsen tissue damage, causing endothelial dysfunction, which in turn leads to gestational complications (40). The developmental problems of the fetal immune system, triggered by gut dysbiosis, impede neonatal resistance against future allergies, as well as autoimmune diseases and metabolic disorders (41).
IMPACTS ON PREGNANCY OUTCOMES AND CHILD DEVELOPMENT
Abnormalities in maternal microbial populations affect both maternal health outcomes during pregnancy and the development of child health. Research indicates that maternal dysbiosis causes preterm labor and leads to an infant’s low birth weight, together with an increased risk for neonatal infections (42, 43). Scientific research indicates that decreased Lactobacillus species combined with excessive pathogen growth in the vaginal microbiome elevates risks for bacterial vaginosis, pregnancy failure, and pregnancy complications (44).
Long-term microbial dysbiosis causes adverse effects that damage both neurodevelopmental well-being and metabolic processes, as well as immune system health (45, 46). Delayed neural communication resulting from gut-brain axis problems makes newborn children at risk for developing asthma alongside obesity and ASD (47). Early microbial colonization, which occurs because of cesarean delivery and antibiotic exposure, leads to higher probabilities of developing allergic diseases and metabolic syndromes in infants (48).
NOVELTY: SYSTEM-LEVEL INTERACTIONS (E.G., GUT-VAGINA AXIS)
The study of dysbiosis brought forward the system-wide microbial relationships, including the gut-vagina axis, which explains maternal microbiome connectivity as a novel approach (49). The composition of vaginal microorganisms experiences potential modifications from maternal pregnancy outcomes because gut dysbiosis appears to regulate immune signaling and microbial metabolite exchanges (50). If this axis becomes disrupted, then pregnant women are at higher risk for bacterial vaginosis and intrauterine infections. Research demonstrates that improving maternal health requires a comprehensive strategy for intervention initiatives (51).
The development of treatment approaches can be based on microbiome science, following the establishment of a better understanding of these complex biological relationships. Maternal health professionals use specific probiotics combined with microbiota transplants alongside dietary interventions to restore microbial balance and decrease sickness threats for both mothers and their children (52).
FUTURE DIRECTIONS
In conclusion, precision medicine strategies demonstrate significant potential to minimize dysbiosis-related health damage in pregnant women and infants (53). The discovery of microbiome-specific treatments, such as individualized probiotics, as well as microbiome transplants and customized dietary approaches, offers new pathways to restore microbial balance (54). Artificial intelligence (AI) integrated with systems biology is increasingly applied to predict disorders associated with dysbiosis (55). Machine learning models can analyze microbial community dynamics, predict outcomes like preterm birth, and even guide personalized microbiome therapeutics by identifying microbial biomarkers (55, 56). Research collaborations across global institutions need to work together to address microbial science inequalities between regions and develop multi-area, region-specific interventions (57). Future research priorities should aim to identify microbiome markers for disease forecasting, while also making microbiome management a critical component of healthcare strategies related to maternal and pediatric care (58). Table 2 outlines potential microbiome-based interventions to mitigate dysbiosis-related health risks in maternal and child populations.
TABLE 2.
Potential microbiome-based interventions, their mechanisms of action, and benefits for maternal and child health
| Intervention | Mechanism of action | Potential benefits | References |
|---|---|---|---|
| Probiotics | Reintroduce beneficial bacteria (e.g., Lactobacillus) | Reduce inflammation, improve pregnancy outcomes | (59) |
| Prebiotics | Promote growth of beneficial gut microbes | Enhance metabolic balance, support immunity | (60, 61) |
| Fecal microbiota transplant | Restore microbial diversity | Mitigate dysbiosis-related complications | (62) |
| Dietary modifications | Adjust nutrient intake to favor healthy microbiota | Decrease risk of obesity, neurodevelopmental issues | (63) |
| Precision microbiome therapies | Target specific microbial imbalances | Personalized treatment for dysbiosis | (64) |
CONCLUSION
Microbial dysbiosis plays a pivotal role in maternal and child health, with far-reaching consequences on immune development, metabolic regulation, and overall well-being. This review underscores how alterations in microbiome composition contribute to inflammatory responses, oxidative stress, and immune dysregulation, ultimately impacting pregnancy outcomes and childhood health trajectories. The gut-vagina axis, a key interaction within the microbiome, underscores the systemic nature of microbial influences on maternal-fetal health. While significant strides have been made in understanding dysbiosis, a substantial gap remains in mechanistic studies across diverse populations, particularly in low-resource settings. There is an urgent need for standardized methodologies, more extensive cohort studies, and multi-omics approaches to elucidate these complex interactions better.
Contributor Information
Umer Ahmed, Email: umeruaf287@gmail.com.
Furrmein Fatima, Email: furrmein8@gmail.com.
Hafiza Amna Farooq, Email: aamnafatimaa13@gmail.com.
Andreas J. Bäumler, University of California Davis, Davis, California, USA
REFERENCES
- 1. Panigrahi P. 2024. The neonatal gut microbiome and global health. Gut Microbes 16:2352175. doi: 10.1080/19490976.2024.2352175 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2. Cerf ME. 2021. Healthy lifestyles and noncommunicable diseases: nutrition, the life‐course, and health promotion, p e31. Wiley Online Library. [Google Scholar]
- 3. Agache I, Akdis C, Akdis M, Al-Hemoud A, Annesi-Maesano I, Balmes J, Cecchi L, Damialis A, Haahtela T, Haber AL. 2024. Immune-mediated disease caused by climate change-associated environmental hazards: mitigation and adaptation. Front Sci 2:1279192. doi: 10.3389/fsci.2024.1279192 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4. Cowardin CA, Syed S, Iqbal N, Jamil Z, Sadiq K, Iqbal J, Ali SA, Moore SR. 2023. Environmental enteric dysfunction: gut and microbiota adaptation in pregnancy and infancy. Nat Rev Gastroenterol Hepatol 20:223–237. doi: 10.1038/s41575-022-00714-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5. Mendz GL. 2023. The vaginal microbiome during pregnancy in health and disease. Appl Microbiol 3:1302–1338. doi: 10.3390/applmicrobiol3040089 [DOI] [Google Scholar]
- 6. Vogenberg FR, Barash CI, Pursel M. 2010. Personalized medicine: part 2: ethical, legal, and regulatory issues. P T 35:624–642. [PMC free article] [PubMed] [Google Scholar]
- 7. Holdcroft AM, Ireland DJ, Payne MS. 2023. The vaginal microbiome in health and disease-what role do common intimate hygiene practices play? Microorganisms 11:298. doi: 10.3390/microorganisms11020298 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8. Romero R, Theis KR, Gomez-Lopez N, Winters AD, Panzer JJ, Lin H, Galaz J, Greenberg JM, Shaffer Z, Kracht DJ, Chaiworapongsa T, Jung E, Gotsch F, Ravel J, Peddada SD, Tarca AL. 2023. The vaginal microbiota of pregnant women varies with gestational age, maternal age, and parity. Microbiol Spectr 11:e0342922. doi: 10.1128/spectrum.03429-22 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9. Khandre V, Potdar J, Keerti A. 2022. Preterm birth: an overview. Cureus 14:e33006. doi: 10.7759/cureus.33006 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10. Lee CC, Feng Y, Yeh YM, Lien R, Chen CL, Zhou YL, Chiu CH. 2021. Gut dysbiosis, bacterial colonization and translocation, and neonatal sepsis in very-low-birth-weight preterm infants. Front Microbiol 12:746111. doi: 10.3389/fmicb.2021.746111 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11. Munasir Z, Khoe LC. 2020. Immune development of children born from caesarean section. World Nutr J 4:17–25. doi: 10.25220/WNJ.V04.S2.0003 [DOI] [Google Scholar]
- 12. Shaterian N, Abdi F, Ghavidel N, Alidost F. 2021. Role of cesarean section in the development of neonatal gut microbiota: a systematic review. Open Med 16:624–639. doi: 10.1515/med-2021-0270 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13. Luo Y, Li M, Luo D, Tang B. 2025. Gut microbiota: an important participant in childhood obesity. Adv Nutr 16:100362. doi: 10.1016/j.advnut.2024.100362 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14. Bornaun T, Guven HZ. 2024. Exploring the impact of prophylactic antibiotics during cesarean delivery on neonatal microbiota: a comprehensive review article. ODÜ Tıp Dergisi 11:129–142. doi: 10.56941/odutip.1538363 [DOI] [Google Scholar]
- 15. Liu F, Li J, Wu F, Zheng H, Peng Q, Zhou H. 2019. Altered composition and function of intestinal microbiota in autism spectrum disorders: a systematic review. Transl Psychiatry 9:43. doi: 10.1038/s41398-019-0389-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16. Liu S, Zhao W, Lan P, Mou X. 2021. The microbiome in inflammatory bowel diseases: from pathogenesis to therapy. Protein Cell 12:331–345. doi: 10.1007/s13238-020-00745-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17. Moya-Alvarez V, Sansonetti PJ. 2022. Understanding the pathways leading to gut dysbiosis and enteric environmental dysfunction in infants: the influence of maternal dysbiosis and other microbiota determinants during early life. FEMS Microbiol Rev 46:fuac004. doi: 10.1093/femsre/fuac004 [DOI] [PubMed] [Google Scholar]
- 18. Singh R, Zogg H, Wei L, Bartlett A, Ghoshal UC, Rajender S, Ro S. 2021. Gut microbial dysbiosis in the pathogenesis of gastrointestinal dysmotility and metabolic disorders. J Neurogastroenterol Motil 27:19–34. doi: 10.5056/jnm20149 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19. Mar Rodríguez M, Pérez D, Javier Chaves F, Esteve E, Marin-Garcia P, Xifra G, Vendrell J, Jové M, Pamplona R, Ricart W, Portero-Otin M, Chacón MR, Fernández Real JM. 2015. Obesity changes the human gut mycobiome. Sci Rep 5:14600. doi: 10.1038/srep14600 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20. Wang Q, Yang Q, Liu X. 2023. The microbiota–gut–brain axis and neurodevelopmental disorders. Protein Cell 14:762–775. doi: 10.1093/procel/pwad026 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21. Bull-Larsen S, Mohajeri MH. 2019. The potential influence of the bacterial microbiome on the development and progression of ADHD. Nutrients 11:2805. doi: 10.3390/nu11112805 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22. Kawabata T, Fukuoka H, Harada M, Shoji K, Kubo Y, Mori C, Sakurai K, Ohkubo T, Oshida K, Yamashiro Y. 2023. Association of fatty acid desaturase 1 rs174547 polymorphism with the composition of long-chain polyunsaturated fatty acids in serum glycerophospholipids during pregnancy. Nutrients 15:722. doi: 10.3390/nu15030722 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23. Koren O, Konnikova L, Brodin P, Mysorekar IU, Collado MC. 2024. The maternal gut microbiome in pregnancy: implications for the developing immune system. Nat Rev Gastroenterol Hepatol 21:35–45. doi: 10.1038/s41575-023-00864-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24. Kimura I, Miyamoto J, Ohue-Kitano R, Watanabe K, Yamada T, Onuki M, Aoki R, Isobe Y, Kashihara D, Inoue D. 2020. Maternal gut microbiota in pregnancy influences offspring metabolic phenotype in mice. Science 367:eaaw8429. doi: 10.1126/science.aaw8429 [DOI] [PubMed] [Google Scholar]
- 25. Hudobenko J, Di Gesù CM, Mooz PR, Petrosino J, Putluri N, Ganesh BP, Rebeles K, Blixt FW, Venna VR, McCullough LD. 2025. Maternal dysbiosis produces long-lasting behavioral changes in offspring. Mol Psychiatry 30:1847–1858. doi: 10.1038/s41380-024-02794-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26. Dingens AS, Fairfortune TS, Reed S, Mitchell C. 2016. Bacterial vaginosis and adverse outcomes among full-term infants: a cohort study. BMC Pregnancy Childbirth 16:278. doi: 10.1186/s12884-016-1073-y [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27. Yang Y, Le Ray I, Zhu J, Zhang J, Hua J, Reilly M. 2021. Preeclampsia prevalence, risk factors, and pregnancy outcomes in Sweden and China. JAMA Netw Open 4:e218401. doi: 10.1001/jamanetworkopen.2021.8401 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28. Torres-Torres J, Basurto-Serrano JA, Camacho-Martinez ZA, Guadarrama-Sanchez FR, Monroy-Muñoz IE, Perez-Duran J, Solis-Paredes JM, Martinez-Portilla R, Espino-Y-Sosa S, Ramirez-Gonzalez A, Guadarrama-Mora R, Rojas-Zepeda L. 2025. Microbiota dysbiosis: a key modulator in preeclampsia pathogenesis and its therapeutic potential. Microorganisms 13:245. doi: 10.3390/microorganisms13020245 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29. Chen X, Li P, Liu M, Zheng H, He Y, Chen M-X, Tang W, Yue X, Huang Y, Zhuang L, Wang Z, Zhong M, Ke G, Hu H, Feng Y, Chen Y, Yu Y, Zhou H, Huang L. 2020. Gut dysbiosis induces the development of pre-eclampsia through bacterial translocation. Gut 69:513–522. doi: 10.1136/gutjnl-2019-319101 [DOI] [PubMed] [Google Scholar]
- 30. Baud A, Hillion K-H, Plainvert C, Tessier V, Tazi A, Mandelbrot L, Poyart C, Kennedy SP. 2023. Microbial diversity in the vaginal microbiota and its link to pregnancy outcomes. Sci Rep 13:9061. doi: 10.1038/s41598-023-36126-z [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31. Catassi G, Mateo SG, Occhionero AS, Esposito C, Giorgio V, Aloi M, Gasbarrini A, Cammarota G, Ianiro G. 2024. The importance of gut microbiome in the perinatal period. Eur J Pediatr 183:5085–5101. doi: 10.1007/s00431-024-05795-x [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32. Gestels T, Vandenplas Y. 2023. Prenatal and perinatal antibiotic exposure and long-term outcome. Pediatr Gastroenterol Hepatol Nutr 26:135–145. doi: 10.5223/pghn.2023.26.3.135 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33. Korpela K. 2021. Impact of delivery mode on infant gut microbiota. Ann Nutr Metab:1–9. doi: 10.1159/000518498 [DOI] [PubMed] [Google Scholar]
- 34. Coelho GDP, Ayres LFA, Barreto DS, Henriques BD, Prado MRMC, Passos CMD. 2021. Acquisition of microbiota according to the type of birth: an integrative review. Rev Lat Am Enfermagem 29:e3446. doi: 10.1590/1518.8345.4466.3446 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35. Madan JC, Hoen AG, Lundgren SN, Farzan SF, Cottingham KL, Morrison HG, Sogin ML, Li H, Moore JH, Karagas MR. 2016. Association of cesarean delivery and formula supplementation with the intestinal microbiome of 6-Week-old infants. JAMA Pediatr 170:212–219. doi: 10.1001/jamapediatrics.2015.3732 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36. Huang T, Liang X, Bao H, Ma G, Tang X, Luo H, Xiao X. 2024. Multi-omics analysis reveals the associations between altered gut microbiota, metabolites, and cytokines during pregnancy. mSystems 9:e0125223. doi: 10.1128/msystems.01252-23 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37. Mostafavi Abdolmaleky H, Zhou JR. 2024. Gut microbiota dysbiosis, oxidative stress, inflammation, and epigenetic alterations in metabolic diseases. Antioxidants (Basel) 13:985. doi: 10.3390/antiox13080985 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38. Martini S, Aceti A, Della Gatta AN, Beghetti I, Marsico C, Pilu G, Corvaglia L. 2023. Antenatal and postnatal sequelae of oxidative stress in preterm infants: a narrative review targeting pathophysiological mechanisms. Antioxidants (Basel) 12:422. doi: 10.3390/antiox12020422 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39. Long D, Liu M, Li H, Song J, Jiang X, Wang G, Yang X. 2021. Dysbacteriosis induces abnormal neurogenesis via LPS in a pathway requiring NF-κB/IL-6. Pharmacol Res 167:105543. doi: 10.1016/j.phrs.2021.105543 [DOI] [PubMed] [Google Scholar]
- 40. Santana PT, Rosas SLB, Ribeiro BE, Marinho Y, de Souza HSP. 2022. Dysbiosis in inflammatory bowel disease: pathogenic role and potential therapeutic targets. Int J Mol Sci 23:3464. doi: 10.3390/ijms23073464 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41. Lin C, Lin Y, Zhang H, Wang G, Zhao J, Zhang H, Chen W. 2022. Intestinal “infant-type” bifidobacteria mediate immune system development in the first 1000 days of life. Nutrients 14:1498. doi: 10.3390/nu14071498 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42. Wong E, Lui K, Day AS, Leach ST. 2022. Manipulating the neonatal gut microbiome: current understanding and future perspectives. Arch Dis Child Fetal Neonatal Ed 107:346–350. doi: 10.1136/archdischild-2021-321922 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43. Underwood MA, Mukhopadhyay S, Lakshminrusimha S, Bevins CL. 2020. Neonatal intestinal dysbiosis. J Perinatol 40:1597–1608. doi: 10.1038/s41372-020-00829-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44. Donald K, Finlay BB. 2023. Early-life interactions between the microbiota and immune system: impact on immune system development and atopic disease. Nat Rev Immunol 23:735–748. doi: 10.1038/s41577-023-00874-w [DOI] [PubMed] [Google Scholar]
- 45. Dogra SK, Kwong Chung C, Wang D, Sakwinska O, Colombo Mottaz S, Sprenger N. 2021. Nurturing the early life gut microbiome and immune maturation for long term health. Microorganisms 9:2110. doi: 10.3390/microorganisms9102110 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46. Cerdó T, Diéguez E, Campoy C. 2019. Early nutrition and gut microbiome: interrelationship between bacterial metabolism, immune system, brain structure, and neurodevelopment. Am J Physiol Endocrinol Metab 317:E617–E630. doi: 10.1152/ajpendo.00188.2019 [DOI] [PubMed] [Google Scholar]
- 47. Beckers KF, Flanagan JP, Sones JL. 2024. Microbiome and pregnancy: focus on microbial dysbiosis coupled with maternal obesity. Int J Obes 48:439–448. doi: 10.1038/s41366-023-01438-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48. Qu W, Liu L, Miao L. 2021. Exposure to antibiotics during pregnancy alters offspring outcomes. Expert Opin Drug Metab Toxicol 17:1165–1174. doi: 10.1080/17425255.2021.1974000 [DOI] [PubMed] [Google Scholar]
- 49. Takada K, Melnikov VG, Kobayashi R, Komine-Aizawa S, Tsuji NM, Hayakawa S. 2023. Female reproductive tract-organ axes. Front Immunol 14:1110001. doi: 10.3389/fimmu.2023.1110001 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50. Salliss ME, Farland LV, Mahnert ND, Herbst-Kralovetz MM. 2021. The role of gut and genital microbiota and the estrobolome in endometriosis, infertility and chronic pelvic pain. Hum Reprod Update 28:92–131. doi: 10.1093/humupd/dmab035 [DOI] [PubMed] [Google Scholar]
- 51. Abu Y, Roy S. 2025. Intestinal dysbiosis during pregnancy and microbiota-associated impairments in offspring. Front Microbiomes 4:1548650. doi: 10.3389/frmbi.2025.1548650 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52. Santos FP, Carvalhos CA, Figueiredo-Dias M. 2023. New insights into photobiomodulation of the vaginal microbiome-a critical review. Int J Mol Sci 24:13507. doi: 10.3390/ijms241713507 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53. Behzadi P, Dodero VI, Golubnitschaja O. 2024. Systemic inflammation as the health-related communication tool between the human host and gut microbiota in the framework of predictive, preventive, and personalized medicine, in All around suboptimal health: advanced approaches by predictive, preventive and personalised medicine for healthy populations, p 203–241. Springer. [Google Scholar]
- 54. Huang G, Khan R, Zheng Y, Lee PC, Li Q, Khan I. 2023. Exploring the role of gut microbiota in advancing personalized medicine. Front Microbiol 14:1274925. doi: 10.3389/fmicb.2023.1274925 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55. Helmy M, Smith D, Selvarajoo K. 2020. Systems biology approaches integrated with artificial intelligence for optimized metabolic engineering. Metab Eng Commun 11:e00149. doi: 10.1016/j.mec.2020.e00149 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56. Etekochay MO, Muraleedharan D, Majumdar S, Nsengiyumva M. 2024. Advancing precision nutrition in endometriosis care: the role of nutrigenomics and nutrigenetics. Academic Medicine & Surgery. doi: 10.62186/001c.124784 [DOI] [Google Scholar]
- 57. Aryal S, Manandhar I, Mei X, Yeoh BS, Tummala R, Saha P, Osman I, Zubcevic J, Durgan DJ, Vijay-Kumar M, Joe B. 2023. Combating hypertension beyond genome-wide association studies: microbiome and artificial intelligence as opportunities for precision medicine. Camb Prism Precis Med 1:e26. doi: 10.1017/pcm.2023.13 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58. Pammi M, Aghaeepour N, Neu J. 2023. Multiomics, artificial intelligence, and precision medicine in perinatology. Pediatr Res 93:308–315. doi: 10.1038/s41390-022-02181-x [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59. Latif A, Shehzad A, Niazi S, Zahid A, Ashraf W, Iqbal MW, Rehman A, Riaz T, Aadil RM, Khan IM, Özogul F, Rocha JM, Esatbeyoglu T, Korma SA. 2023. Probiotics: mechanism of action, health benefits and their application in food industries. Front Microbiol 14:1216674. doi: 10.3389/fmicb.2023.1216674 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60. Guarino MPL, Altomare A, Emerenziani S, Di Rosa C, Ribolsi M, Balestrieri P, Iovino P, Rocchi G, Cicala M. 2020. Mechanisms of action of prebiotics and their effects on gastro-intestinal disorders in adults. Nutrients 12:1037. doi: 10.3390/nu12041037 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61. Gálvez-Ontiveros Y, Páez S, Monteagudo C, Rivas A. 2020. Endocrine disruptors in food: impact on gut microbiota and metabolic diseases. Nutrients 12:1158. doi: 10.3390/nu12041158 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62. Bloom PP, Pasricha TS, Viveiros K. 2020. We know liver biochemistries are elevated in COVID-19, but should we be concerned? Clin Gastroenterol Hepatol 18:2384–2385. doi: 10.1016/j.cgh.2020.05.018 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63. Kumar S, Mukherjee R, Gaur P, Leal É, Lyu X, Ahmad S, Puri P, Chang C-M, Raj VS, Pandey RP. 2025. Unveiling roles of beneficial gut bacteria and optimal diets for health. Front Microbiol 16:1527755. doi: 10.3389/fmicb.2025.1527755 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 64. Abeltino A, Hatem D, Serantoni C, Riente A, De Giulio MM, De Spirito M, De Maio F, Maulucci G. 2024. Unraveling the gut microbiota: implications for precision nutrition and personalized medicine. Nutrients 16:3806. doi: 10.3390/nu16223806 [DOI] [PMC free article] [PubMed] [Google Scholar]

